We are live on ! Find out more
MRNX icon

Defiance Daily Target 2X Long MRNA ETF

7 hedge funds and large institutions have $2.41M invested in Defiance Daily Target 2X Long MRNA ETF in 2026 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,220% more capital inflows, than outflows

Capital inflows: $1.05M | Capital outflows: $6.82K

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

250% more funds holding

Funds holding: 2 → 7 (+5)

188% more call options, than puts

Call options by funds: $6.37M | Put options by funds: $2.21M

2.55% less ownership

Funds ownership: 2.55% → 0% (-2.6%)

Holders
7
Holders Change
+5
Holders Change %
+250%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
1
Calls
$6.37M
Puts
$2.21M
Net Calls
+$4.16M
Net Calls Change
+$4.16M

MRNX Hedge Fund Activity: Q3 2026 in Review

7 of the 8,160 institutional investors tracked by Wall St. Rank reported a position in Defiance Daily Target 2X Long MRNA ETF (MRNX) for Q3 2026, worth a combined $2.41M — up 2,364% from $97.9K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MRNX positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $344K. The largest seller was McGuire Capital Advisors, exiting entirely with an estimated $6.82K sold.

  • 7 institutional investors held Defiance Daily Target 2X Long MRNA ETF (MRNX) as of Q3 2026, up from 2 in Q2 2026.
  • Funds reported $2.41M of Defiance Daily Target 2X Long MRNA ETF stock for Q3 2026, up 2,364% quarter-over-quarter.
  • 6 funds opened new Defiance Daily Target 2X Long MRNA ETF positions in Q3 2026 and 1 closed out, a net change of +5 holders.
  • The largest Defiance Daily Target 2X Long MRNA ETF buyer in Q3 2026 was Susquehanna International Group, an estimated $344K added.
  • The largest Defiance Daily Target 2X Long MRNA ETF seller in Q3 2026 was McGuire Capital Advisors, an estimated $6.82K sold.

Based on aggregated 13F filings for Q3 2026.